Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting, 9747 [2014-03634]
Download as PDF
Federal Register / Vol. 79, No. 34 / Thursday, February 20, 2014 / Notices
improve these practices, processes, or
systems.
11. Are there current practices,
processes, or systems that could be used
to exchange information between
supply chain stakeholders or with FDA
to respond to requests to verify the lot
number, expiration date, and other
indices of identity assigned to a product
by the manufacturer or repackager (i.e.,
requests for verification of suspect
product)? Are these practices, processes,
or systems effective? If not, please
provide recommendations to improve
these practices, processes, or systems.
12. Are there current practices,
processes, or systems that could be used
for providing information in response to
requests from FDA or other appropriate
Federal or State officials in the event of
a recall or for the purpose of
investigating a suspect or illegitimate
product? Are these practices, processes,
or systems effective? If not, please
provide recommendations to improve
these practices, processes, or systems.
Question related to capturing
information that has not necessarily
been addressed by the previous
questions:
13. Are there other considerations
related to standards for the
interoperable exchange of information
for tracing of human, finished,
prescription drugs that have not been
addressed by the previous questions?
Please provide any additional
information that you think could be
helpful for the Agency to consider as it
implements these provisions of the
DSCSA.
mstockstill on DSK4VPTVN1PROD with NOTICES
III. Submission of Comments
Interested persons may submit either
electronic comments regarding this
document to https://www.regulations.gov
or written comments to the Division of
Dockets Management (see ADDRESSES). It
is only necessary to send one set of
comments. Identify comments with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday, and
will be posted to the docket at https://
www.regulations.gov.
Dated: February 13, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014–03592 Filed 2–19–14; 8:45 am]
BILLING CODE 4160–01–P
VerDate Mar<15>2010
18:08 Feb 19, 2014
Jkt 232001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Notice of Diabetes Mellitus Interagency
Coordinating Committee Meeting
The Diabetes Mellitus
Interagency Coordinating Committee
(DMICC) will hold a meeting on March
12, 2014 from 1:00 to 4:00 p.m. at the
Natcher Conference Center (Building 45)
Conference Room E1/E2, on the NIH
Campus in Bethesda, MD. The topic for
this meeting will be ‘‘Future Needs and
Direction of Surveillance of Diabetes in
Youth and Young Adults.’’ The meeting
is open to the public.
DATES: The meeting will be held on
March 12, 2014 from 1:00 to 4:00 p.m.
Individuals wanting to present oral
comments must notify the contact
person at least 10 days before the
meeting date.
ADDRESSES: The meeting will be held at
the Natcher Conference Center (Building
45) Conference Room E1/E2, on the NIH
Campus in Bethesda, MD.
FOR FURTHER INFORMATION CONTACT: For
further information concerning this
meeting, see the DMICC Web site,
www.diabetescommittee.gov, or contact
Dr. B. Tibor Roberts, Executive
Secretary of the Diabetes Mellitus
Interagency Coordinating Committee,
National Institute of Diabetes and
Digestive and Kidney Diseases, 31
Center Drive, Building 31A, Room
9A19, MSC 2560, Bethesda, MD 20892–
2560, telephone: 301–496–6623; FAX:
301–480–6741; email: dmicc@
mail.nih.gov.
SUMMARY:
The
DMICC, chaired by the National
Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK) comprising
members of the Department of Health
and Human Services and other federal
agencies that support diabetes-related
activities, facilitates cooperation,
communication, and collaboration on
diabetes among government entities.
DMICC meetings, held several times a
year, provide an opportunity for
Committee members to learn about and
discuss current and future diabetes
programs in DMICC member
organizations and to identify
opportunities for collaboration. The
March 12, 2014 DMICC meeting will
focus on ‘‘Future Needs and Direction of
Surveillance of Diabetes in Youth and
Young Adults.’’
Any member of the public interested
in presenting oral comments to the
Committee should notify the contact
person listed on this notice at least 10
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00020
Fmt 4703
Sfmt 4703
9747
days in advance of the meeting.
Interested individuals and
representatives or organizations should
submit a letter of intent, a brief
description of the organization
represented, and a written copy of their
oral presentation in advance of the
meeting. Only one representative of an
organization will be allowed to present;
oral comments and presentations will be
limited to a maximum of 5 minutes.
Printed and electronic copies are
requested for the record. In addition,
any interested person may file written
comments with the Committee by
forwarding their statement to the
contact person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Because of time constraints for the
meeting, oral comments will be allowed
on a first-come, first-serve basis.
Members of the public who would
like to receive email notification about
future DMICC meetings should register
for the listserv available on the DMICC
Web site, www.diabetescommittee.gov.
Dated: February 12, 2014.
B. Tibor Roberts,
Executive Secretary, DMICC, Office of
Scientific Program and Policy Analysis,
National Institute of Diabetes and Digestive
and Kidney Diseases, National Institutes of
Health.
[FR Doc. 2014–03634 Filed 2–19–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF THE INTERIOR
Office of the Secretary
[DR.5B211.IA000713]
List of Programs Eligible for Inclusion
in Fiscal Year 2014 Funding
Agreements To Be Negotiated With
Self-Governance Tribes by Interior
Bureaus Other Than the Bureau of
Indian Affairs
Office of the Secretary, Interior.
Notice.
AGENCY:
ACTION:
This notice lists programs or
portions of programs that are eligible for
inclusion in Fiscal Year 2014 funding
agreements with self-governance Indian
tribes and lists programmatic targets for
each of the non-Bureau of Indian Affairs
(BIA) bureaus in the Department of the
Interior, pursuant to the Tribal SelfGovernance Act.
DATES: This notice expires on
September 30, 2014.
ADDRESSES: Inquiries or comments
regarding this notice may be directed to
SUMMARY:
E:\FR\FM\20FEN1.SGM
20FEN1
Agencies
[Federal Register Volume 79, Number 34 (Thursday, February 20, 2014)]
[Notices]
[Page 9747]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-03634]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Diabetes Mellitus Interagency Coordinating Committee
Meeting
SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee
(DMICC) will hold a meeting on March 12, 2014 from 1:00 to 4:00 p.m. at
the Natcher Conference Center (Building 45) Conference Room E1/E2, on
the NIH Campus in Bethesda, MD. The topic for this meeting will be
``Future Needs and Direction of Surveillance of Diabetes in Youth and
Young Adults.'' The meeting is open to the public.
DATES: The meeting will be held on March 12, 2014 from 1:00 to 4:00
p.m. Individuals wanting to present oral comments must notify the
contact person at least 10 days before the meeting date.
ADDRESSES: The meeting will be held at the Natcher Conference Center
(Building 45) Conference Room E1/E2, on the NIH Campus in Bethesda, MD.
FOR FURTHER INFORMATION CONTACT: For further information concerning
this meeting, see the DMICC Web site, www.diabetescommittee.gov, or
contact Dr. B. Tibor Roberts, Executive Secretary of the Diabetes
Mellitus Interagency Coordinating Committee, National Institute of
Diabetes and Digestive and Kidney Diseases, 31 Center Drive, Building
31A, Room 9A19, MSC 2560, Bethesda, MD 20892-2560, telephone: 301-496-
6623; FAX: 301-480-6741; email: dmicc@mail.nih.gov.
SUPPLEMENTARY INFORMATION: The DMICC, chaired by the National Institute
of Diabetes and Digestive and Kidney Diseases (NIDDK) comprising
members of the Department of Health and Human Services and other
federal agencies that support diabetes-related activities, facilitates
cooperation, communication, and collaboration on diabetes among
government entities. DMICC meetings, held several times a year, provide
an opportunity for Committee members to learn about and discuss current
and future diabetes programs in DMICC member organizations and to
identify opportunities for collaboration. The March 12, 2014 DMICC
meeting will focus on ``Future Needs and Direction of Surveillance of
Diabetes in Youth and Young Adults.''
Any member of the public interested in presenting oral comments to
the Committee should notify the contact person listed on this notice at
least 10 days in advance of the meeting. Interested individuals and
representatives or organizations should submit a letter of intent, a
brief description of the organization represented, and a written copy
of their oral presentation in advance of the meeting. Only one
representative of an organization will be allowed to present; oral
comments and presentations will be limited to a maximum of 5 minutes.
Printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
Committee by forwarding their statement to the contact person listed on
this notice. The statement should include the name, address, telephone
number and when applicable, the business or professional affiliation of
the interested person. Because of time constraints for the meeting,
oral comments will be allowed on a first-come, first-serve basis.
Members of the public who would like to receive email notification
about future DMICC meetings should register for the listserv available
on the DMICC Web site, www.diabetescommittee.gov.
Dated: February 12, 2014.
B. Tibor Roberts,
Executive Secretary, DMICC, Office of Scientific Program and Policy
Analysis, National Institute of Diabetes and Digestive and Kidney
Diseases, National Institutes of Health.
[FR Doc. 2014-03634 Filed 2-19-14; 8:45 am]
BILLING CODE 4140-01-P